Spice Of Life
On sale on the US market (according to the DSLD)
ProCaps Laboratories, food supplement from the US market
Spice Of Life (ProCaps Laboratories), a food supplement without a usable barcode in DSLD, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- ProCaps Laboratories
- Barcode
- Not provided or invalid in DSLD
- Form
- Capsule
- One serving
- 1 capsule
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Gelatin Capsule
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Garlic (Allium sativum) | Plant | 200 mg |
| Proprietary Activated Curcumin-Phospholipid Complex | Other substance | 40 mg |
| Turmeric (Curcuma longa) | Plant | not stated |
| Sunflower Phospholipids | Fat | not stated |
| Oregano Blend | Plant | 40 mg |
| Rosemary | Plant | 40 mg |
| Sage (Salvia officinalis) | Plant | 40 mg |
| Thyme (Thymus vulgaris) | Plant | 40 mg |
| Mustard (Sinapis alba) | Plant | 20 mg |
| Wasabi | Plant | 20 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Spice of Life
Entered into DSLD on 22 November 2024. Withdrawn from the US market on 14 February 2025 (according to the DSLD).- Active ingredient added : Allicin (quantity not stated)
- Active ingredient added : Alliin (quantity not stated)
- Active ingredient added : Curcumin Phospholipid Complex (40 mg)
- Active ingredient added : Mustard Seed Extract (20 mg)
- Active ingredient added : Oregano Leaf Extract (40 mg)
- Active ingredient added : Rosemary Leaf Extract (40 mg)
- Active ingredient added : Sage Leaf Extract (40 mg)
- Active ingredient added : Thyme Leaf Extract Concentrate (40 mg)
- Active ingredient added : Wasabi Root Extract (20 mg)
- Active ingredient removed : Mustard (20 mg)
- Active ingredient removed : Oregano Blend (40 mg)
- Active ingredient removed : Proprietary Activated Curcumin-Phospholipid Complex (40 mg)
- Active ingredient removed : Rosemary (40 mg)
- Active ingredient removed : Sage (40 mg)
- Active ingredient removed : Sunflower Phospholipids (quantity not stated)
- Active ingredient removed : Thyme (40 mg)
- Active ingredient removed : Turmeric (quantity not stated)
- Active ingredient removed : Wasabi (20 mg)
- Same quantity, different name: Garlic Bulb Concentrate in this version; Garlic on the displayed label (200 mg)
Official label: Spice of Life
Entered into DSLD on 24 October 2022. Withdrawn from the US market on 13 December 2023 (according to the DSLD).- Active ingredient added : Curcumin Phospholipid Complex (40 mg)
- Active ingredient added : Mustard Seed Extract (20 mg)
- Active ingredient added : Oregano Leaf Extract (40 mg)
- Active ingredient added : Rosemary Leaf Extract (40 mg)
- Active ingredient added : Sage Leaf Extract (40 mg)
- Active ingredient added : Thyme Leaf Extract (40 mg)
- Active ingredient added : Wasabi Root Extract (20 mg)
- Active ingredient removed : Mustard (20 mg)
- Active ingredient removed : Oregano Blend (40 mg)
- Active ingredient removed : Proprietary Activated Curcumin-Phospholipid Complex (40 mg)
- Active ingredient removed : Rosemary (40 mg)
- Active ingredient removed : Sage (40 mg)
- Active ingredient removed : Sunflower Phospholipids (quantity not stated)
- Active ingredient removed : Thyme (40 mg)
- Active ingredient removed : Turmeric (quantity not stated)
- Active ingredient removed : Wasabi (20 mg)
Official label: Spice Of Life
Entered into DSLD on 22 May 2020. Withdrawn from the US market on 4 February 2022 (according to the DSLD).- Active ingredient added : Curcumin Phospholipid Complex (40 mg)
- Active ingredient added : Mustard Seed Extract (20 mg)
- Active ingredient added : Oregano Leaf Extract (40 mg)
- Active ingredient added : Rosemary Leaf Extract (40 mg)
- Active ingredient added : Sage Leaf Extract (40 mg)
- Active ingredient added : Thyme Leaf Extract (40 mg)
- Active ingredient added : Wasabi Root Extract (20 mg)
- Active ingredient removed : Mustard (20 mg)
- Active ingredient removed : Oregano Blend (40 mg)
- Active ingredient removed : Proprietary Activated Curcumin-Phospholipid Complex (40 mg)
- Active ingredient removed : Rosemary (40 mg)
- Active ingredient removed : Sage (40 mg)
- Active ingredient removed : Sunflower Phospholipids (quantity not stated)
- Active ingredient removed : Thyme (40 mg)
- Active ingredient removed : Turmeric (quantity not stated)
- Active ingredient removed : Wasabi (20 mg)
Official label: Spice Of Life
Entered into DSLD on 24 January 2014. On sale on the US market (according to the DSLD).- Active ingredient added : Onion (100 mg)
- Active ingredient removed : Mustard (20 mg)
- Active ingredient removed : Proprietary Activated Curcumin-Phospholipid Complex (40 mg)
- Active ingredient removed : Sunflower Phospholipids (quantity not stated)
- Active ingredient removed : Wasabi (20 mg)
- Different unit, without conversion : Turmeric: 40 mg in this version; quantity not stated on the displayed label
Official label: Spice Of Life
Entered into DSLD on 25 January 2012. Withdrawn from the US market on 1 January 2012 (according to the DSLD).- Active ingredient added : Onion (100 mg)
- Active ingredient removed : Mustard (20 mg)
- Active ingredient removed : Proprietary Activated Curcumin-Phospholipid Complex (40 mg)
- Active ingredient removed : Sunflower Phospholipids (quantity not stated)
- Active ingredient removed : Wasabi (20 mg)
- Different unit, without conversion : Turmeric: 40 mg in this version; quantity not stated on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Garlic
Read the warning, when it applies and the studies cited
Garlic - Allium sativum
Route of administration: Oral
Cautions and warnings
Condition of application: Relief of upper respiratory tract infections and catarrhal (nasal congestion) conditions.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All uses.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or protease inhibitors (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
- Turmeric
Read the warning, when it applies and the studies cited
TURMERIC - CURCUMA LONGA - Oral
Route of administration: Oral (ESCOP 2003; Blumenthal et al. 2000)
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (ESCOP 2003; Brinker 2001; McGuffin et al. 1997).
Sources cited by Health Canada (2)
- ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder (HC 2025; EMA 2018; Brinker 2010; ESCOP 2003; McGuffin et al. 1997).
Sources cited by Health Canada (6)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2018. European Medicines Agency. European Union herbal monograph on Curcuma longa L., rhizome. London (GB): EMA Committee on Herbal Medicinal Products (HMPC); 25 September 2018. [Accessed 2023 October 14] Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-curcuma-longa-l-rhizoma-revision-1_en.pdf
- ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications (HC 2025).
Sources cited by Health Canada (2)
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain (HC 2025).
Sources cited by Health Canada (2)
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Condition of application: All uses except for Source of antioxidants and Hepatoprotectant.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 26 September 2025
Turmeric -CURCUMA LONGA - Topical
Cautions and warnings
For external use only.
When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Contraindications
Do not use on deep or puncture wounds, animal bites or serious burns.
- Sage
Read the warning, when it applies and the studies cited
SAGE - SALVIA OFFICINALIS - Buccal
Cautions and warnings
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Health Canada monograph dated 28 March 2025
SAGE -SALVIA OFFICINALIS Oral
Cautions and warnings
Condition of application: Carminative, Diaphoretic, Antihidrotic, Antigalactagogue.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Condition of application: All products.
Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Bradley 2006; Mills and Bone 2005).
Sources cited by Health Canada (3)
- Bradley PR, editor. 2006: Bradley PR, editor. British Herbal Compendium Volume 2: A Handbook of Scientific Information on Widely Used Plant Drug-Companion to the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 2006.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Raton (FL): Taylor and Francis Group; 2013.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Do not use if you have a seizure disorder such as epilepsy (Gardner and McGuffin 2013; Bradley 2006; Mills and Bone 2005).
Sources cited by Health Canada (3)
- Bradley PR, editor. 2006: Bradley PR, editor. British Herbal Compendium Volume 2: A Handbook of Scientific Information on Widely Used Plant Drug-Companion to the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 2006.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Raton (FL): Taylor and Francis Group; 2013.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
- Thyme
Read the warning, when it applies and the studies cited
THYME - THYMUS VULGARIS - Buccal
Route of administration: Buccal (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Health Canada monograph dated 28 March 2025
THYME - THYMUS VULGARIS - Oral
Route of administration: Oral (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant.
Health Canada monograph dated 26 June 2026
THYME - THYMUS VULGARIS - Topical
Route of administration: Topical (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
For external use only.
When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Contraindications
Do not use on deep or puncture wounds, animal bites or serious burns.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : ProCaps Laboratories
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Spice Of Life (ProCaps Laboratories): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/dsld-57597-spice-of-life-procaps-laboratories, updated 24 March 2016.